Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
Bas J. Wouters(Erasmus MC), Ruud Delwel(Erasmus MC Cancer Institute)
Cited by 298
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
PBX3 is an important cofactor of HOXA9 in leukemogenesis
|Blood|2012|170
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
|Haematologica|2008|85
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops
|Nature Communications|2021|76